Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Immunopharmacology

Volumn 39, Issue 3, 1998, Pages 167-180

  Kohutnicka, Małgorzata ^a   Lewandowska, Eliza ^b   Kurkowska Jastrzȩbska, Iwona ^a   Członkowski, Andrzej ^a   Członkowska, Anna ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Dopaminergic neurons; Glia; Interleukin 6; Neurodegeneration; Nigrostriatal system

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; INTERLEUKIN 6; PARGYLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICROGLIA; MOUSE; NERVE DEGENERATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PHAGOCYTOSIS; PRIORITY JOURNAL;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; ASTROCYTES; DISEASE MODELS, ANIMAL; DOPAMINE; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; MICROSCOPY, ELECTRON; MPTP POISONING; PARGYLINE; PARKINSON DISEASE, SECONDARY; SUBSTANTIA NIGRA;

EID: 0032100191     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(98)00022-8     Document Type: Article

References (44)

1. Adams J.D., Kalivas P.W., Miller C.A. The acute histopathology of MPTP in the mouse CNS. Brain Res. Bull. 23:1989;1-17.
2. Aderka D., Le J., Vilcek J. IL-6 inhibits lipopolisacharide-induced tumor necrosis factor production in cultured human monocytes and U937 cells in mice. J. Immunol. 143:1989;3517-3523.
3. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia. 7:1993;111-118.
4. Banati R.B., Schubert P., Rothe G., Gehrmann J., Rudolphi K., Valet G., Kreutzberg G.W. Modulation of intracellular formation of reactive oxygen intermediates in peritoneal macrophages and microglia/brain macrophages by propentophylline. J. Cereb. Blood Flow Metab. 14:1994;145-149.
5. Chao C.C., Hu S., Close K., Choi C.S., Molitor T.W., Novick W.J., Peterson P.K. Cytokine release from microglia: different inhibition by pentoxifylline and dexamethasone. J. Infect. Dis. 166:1992;847-853.
6. Członkowska A., Kohutnicka M., Kurkowska-Jastrzȩbska I., Członkowski A. Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model. Neurodegeneration. 5:1996;137-143.
7. Date I., Felten D.L., Felten S.K. Long-term effect of MPTP in the mouse brain in relation to ageing: neurochemical and immunocytochemical analysis. Brain Res. 519:1990;266-272.
8. Eddelston M., Mucke L. Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience. 54:1993;15-36.
9. Fattori E., Lazzaro D., Musiani P., Modesti A., Alonzi T., Ciliberto G. IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur. J. Neurosci. 7:1995;2441-2449.
10. Francis J.W., von Visger J., Markleonis G.J., Oh T.H. Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse striatum. Neurotoxicol. Neuroteratol. 17:1995;7-12.
11. Frei K., Siepl C., Groscurth P., Bodmer S., Schwerdel C., Fontana A. Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells. Eur. J. Immunol. 17:1987;1271-1278.
12. Frei K., Malipiero U.V., Leist T.P., Zinkernagel R.M., Schwab M.E., Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur. J. Neurosci. 19:1989;686-694.
13. Gehrmann, J., Kreutzberg, G.W., 1995. Microglia in experimental neuropathology. In: Kettenmann, H., Randsom, B. (Eds.), Neuroglilal Cells. Oxford University Press, pp. 883-904.
14. Gehrmann J., Schoen S.W., Kreutzberg G.W. Lesion of the rat entorhinal cortex leads to a rapid microglial reaction in the dentate gyrus. Acta Neuropathol. 82:1991;442-455.
15. Gehrmann J., Gold R., Linnington C., Lannes-Vieira J., Wekerle H., Kreutzberg G.W. Microglial involvement in experimental autoimmune inflammation of the central and peripheral nervous system. Glia. 7:1993;50-59.
16. Giulian D. Reactive glia as rivals in regulating neuronal survival. Glia. 7:1993;102-110.
17. Giulian D., Ingemann J.E. Colony stimulating factors as promotors of ameboid microglia. J. Neurosci. 85:1988;317-321.
18. Giulian D., Lachman L.B. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science. 228:1985;497-499.
19. Giulian D., Vaca K., Corpuz M. Brain glia release factors with opposing actions upon neuronal survival. J. Neurosci. 13:1993;29-37.
20. Giulian D., Li J., Leara B., Keenen C. Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture. Neurochem. Int. 25:1994;227-233.
21. Graeber M.B., Streit W.J. Microglia: immune network in the CNS. Brain Pathol. 1:1990;2-5.
22. Hama T., Kushima Y., Miamoto M., Kubota M., Takei N., Hatanaka H. Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholonergic neurons from postnatal, two-week-old rats in cultures. Neuroscience. 40:1991;445-452.
23. Heikkila R.E., Sonsalla P.K. The use of the MPTP-treated mouse as an animal model of parkinsonism. Can. J. Neurol. Sci. 14:1987;436-440.
24. Kettenmann H., Banati R., Waltz W. Electrophysiological behavior of microglia. Glia. 7:1993;93-101.
25. Kiefer R., Kreutzberg G.W. Effects of dexamethasone on microglial activation in vivo: Selective downregulation of major histocompatibility complex class II expression in regenerating facial nucleus. J. Neuroimmunol. 34:1991;99-108.
26. Kitt C.A., Cork L.C., Eidelberg E., Joh T.H., Price D.L. Injury of catecholaminergic neurons after acute exposure to MPTP. A TH immunocytochemical study in the monkey. Ann. New York Acad. Sci. 495:1987;730-731.
27. Klein M.A., Müller J.C., Jones L.L., Bluethmann H., Kreutzberg G.W., Raivich G. Impaired neuroglial activation in interleukin-6 deficient mouse. Glia. 19:1997;227-233.
28. Kopin I.J. Features of the dopaminergic neurotoxin MPTP. Ann. New York Acad. Sci. 648:1992;96-104.
29. Kushima Y., Hama T., Hatanaka H. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains. Neurosci. Res. 13:1992;267-280.
30. Langeveld C.H., Jongenelen C.A.M., Schepens E., Stoof J.C., Bast A., Drukarch B. Cultured rat striatal and cortical astrocytes protect mesencephalic dopaminergic neurons against hydrogen peroxide toxicity independent of their effect on neuronal development. Neurosci. Lett. 192:1995;13-16.
31. Langston J.W., Irwin I., Langston E.B., Forno L.S. Pargyline prevents MPTP-induced Parkinsonism in primates. Science. 225:1984;1480-1482.
32. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 38:1988;1285-1291.
33. McGeer P.L., McGeer E.G., Kawamata T., Yamada T., Akiyama H. Reactions of the immune system in chronic degenerative neurological diseases. Can. J. Neurol. Sci. 18:1991;376-379.
34. Michael D., Norenberg M.D. Astrocyte responses to CNS injury. J. Neuropathol. Exp. Neurol. 53:1994;213-220.
35. Müller H.W., Junghans U., Keppler J. Astroglial neurotrophic and neurite-promoting factors. Pharmacol. Ther. 65:1995;1-18.
36. Nohava K., Malipiero U., Frei K., Fontana A. Neurons and neuroblastoma as a source of macrophage colony-stimulating factor. Eur. J. Immunol. 22:1992;2539-2545.
37. O'Callaghan J.P., Miller D.B., Reinhard J.F. Jr. Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Brain Res. 521:1990;73-80.
38. Raivich G., Moreno-Flores T., Möller J.C., Kreutzberg G.W. Inhibition of posttraumatic microglial proliferation in a genetic model of macrophage colony-stimulating factor deficiency in mouse. Eur. J. Neurosci. 6:1994;1616-1618.
39. Reinhard J.F. Jr., Miller D.B., O'Callaghan J.P. The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibryllary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury. Neurosci. Lett. 95:1988;246-251.
40. Ricaurete G.A., Irwin I., Forno L.S., De Lanney L.E., Langston E., Langston J.W. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra. Brain Res. 403:1987;45-51.
41. Schöbitz B., de Kloet E.R., Sutanto W., Holsboer F. Cellular localization of interleukin-6 mRNA and interleukin-6 receptor mRNA in rat brain. Eur. J. Neurosci. 5:1993;1426-1435.
42. Shrikant P.S., Benveniste E.N. The central nervous system as an immunocompetent organ. J. Immunol. 157:1996;1819-1822.
43. Sonsalla P.K., Heikkila R.E. The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice. Eur. J. Pharmacol. 129:1986;339-345.
44. Sundström, E., Henriksson, B.G., Mohammed, A.H., Souverbie, F., 1994. MPTP-treated mice: a useful model for Parkinson's disease? In: Woodruff, M.L., Nonneman, A.J. (Eds.), Toxin-induced models of neurological disorders. Plenum, New York, pp. 121-137.